AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 5c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.64), $0.05 worse than the analyst estimate of ($1.59).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue